Tai WC, Yang SC, Yao CC, Wu CK , Liu AC, Lee CH, Kuo YH, Chuah SK*, Liang CM*. The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naive Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial. Infect Dis Ther. 2023 May;12(5):1415-1427. (SCI)
Lin CY, Wu KL*, Yao CC, Tsai CE, Tai WC, Liang CM, Chou YP, Chuah SK*. Clinical characteristics and esophageal motility in Sjogren's syndrome: A single-center study in Taiwan. Adv Dig Med. 2021 Dec; 8(4):218-223. (台灣消化醫學雜誌)
Lai WT#, Chiu SM#, Wu CK, Liang CM, Yang SH, Yao CC, Kuo CM, Lu LS*, Chiu YC, Wu KL, Tai WC, Chuah SK*. Incidence of interval colorectal cancer: A tertiary hospital report. Adv Dig Med. 2021 Sept.; 8(3): 172-177. (台灣消化醫學雜誌)
Yang SC, Wu CK, Tai WC, Liang CM, Yao CC, Wu KL, Hsu CN*, Chuah SK*. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding. J Gastroenterol Hepatol. 2021 Jul;36(7):1828-1835. (SCI)
Hung KT, Yang SC, Wu CK, Wang HM, Yao CC, Liang CM*, Tai WC, Wu KL, Kuo YH, Lee CH, Chuah SK*. Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice. Infect Drug Resist. 2021 Mar.; 2021(14):1239-1246. (SCI)
Tai WC, Wu KL*, Chuah SK*. An update on endoscopic treatment for achalasia: From peroral endoscopic myotomy to endolumenal functional lumen imaging probe. Adv Dig Med. 2021 Mar;8:8–9. (EDITORIAL) (台灣消化醫學雜誌)
Liang CM, Tai WC, Hsu PI, Wu DC, Kuo CH, Tsay FW, Lee CL, Chen KY*, Chuah SK*. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan. Therap Adv Gastroenterol. 2020 Dec 10;13:1756284820976990. (SCI)
Yang SC, Wu CK, Tai WC, Liang CM, Li YC, Yeh WS, Lee CH, Yang YH, Tsai TH, Hsu CN*, Chuah SK*. Incidence and risk factors of colonoscopic post-polypectomy bleeding and perforation in patients with end-stage renal disease. J Gastroenterol Hepatol. 2020 Oct;35(10):1704-1711. (SCI)
Wu CK, Yang SC, Liang CM, Li YC, Yeh WS, Tai WC, Lee CH, Yang YH, Hsu CN*, Tsai TH, Chuah SK*. The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. J Gastroenterol Hepatol. 2020 May;35(5):777-787.(SCI)
Liang CM, Yang SC, Wu CK, Li YC, Yeh WS, Tai WC, Lee CH, Yang YH, Tsai TH, Hsu CN*, Chuah SK*. Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs. J Clin Med. 2019 Oct; 8(10): 1722. (SCI)
Tai WC, Liang CM, Bi KW, Kuo CM*, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF, Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK*. A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth. Infect Drug Resist. 2019 Sep 16;12:2923-2931. (SCI)
Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, Kuo YH, Lin MT, Lee CH, Hsu CN, Wu KL, Hu TH, Chuah SK*. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial. J Antimicrob Chemother. 2019 Jun 1;74(6):1718-1724. (SCI)
Chuah SK, Lim CS, Liang CM, Lu HI,Wu KL,Changchien CS, Tai WC*. Bridging the Gap between Advancements in the Evolution of Diagnosis and Treatment towards Better Outcomes in Achalasia. Biomed Res Int. 2019 Feb 6;2019:8549187. (SCI) Review
Huang PY, Tsai KL, Liang CM, Tai WC, Rau KM, Wu KL, Huang CC, Chuah SK*. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms. Kaohsiung J Med Sci. 2018 Nov;34(11):650-656. (SCI)
Wang JW, Tseng KL, Hsu CN, Liang CM, Tai WC, Ku MK, Hung TH, Yuan LT, Nguang SH, Yang SC, Wu CK, Chiu CH, Tsai KL, Chang MW, Huang CF, Hsu PI, Wu DC*, Chuah SK*. Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS One. 2018 Jan 2;13(1):e0190219. (SCI)
Liang CM, Chiu CH, Wang HM, Tai WC, Yao CC,Tsai CE, Kuo CM, Chiu YC, Wu KL, Lee CH*, Tsai KL, Huang CF, Chuah SK*. First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan. Biomed Res Int. 2017;2017:3762194. (SCI)
Liang CM(co-first), Kuo MT(co-first), Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK*, Taiwan Acid-Related Disease Study Group. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol. 2017 Dec 21; 23(47): 8395-8404. (SCI)
Hung TH, Liang CM, Hsu CN, Tai WC, Tsai KL, Ku MK, Wang JW, Tseng KL, Yuan LT, Nguang SH, Yang SC, Wu CK, Hsu PI, Wu DC*, Chuah SK*. Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS One. 2017 Jul 24;12(7):e0181858. (SCI)
Yang SC, Hsu CN, Liang CM, Tai WC, Wu CK, Shih CW, Ku MK, Yuan LT, Wang JW, Tseng KL, Hung TH, Nguang SH, Hsu PI, Wu DC, Chuah SK*. Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.PLoS One. 2017 Jan 12;12(1):e0168918. (SCI)
Wang JW, Hsu CN, Tai WC, Ku MK, Hung TH, Tseng KL, Yuan LT, Nguang SH, Liang CM, Yang SC, Wu CK, Hsu PI, Wu DC*, Chuah SK*. The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases. PLoS One. 2016 Oct 20;11(10):e0164824. (SCI)
Liang CM, Hsu CN, Tai WC, Yang SC, Wu CK, Shih CW, Ku MK, Yuan LT, Wang JW, Tseng KL, Sun WC, Hung TH, Nguang SH, Hsu PI, Wu DC*, Chuah SK*; Taiwan Acid-Related Disease (TARD) Study Group.Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study. Medicine (Baltimore). 2016 Sep;95(36):e4795. (SCI)
Liu CL(co-first), Wu CK*(co-first), Shi HY, Tai WC, Liang CM, Yang SC, Wu KL, Chiu YC, Chuah SK*. Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study. Medicine (Baltimore). 2016 Jul;95(28):e4215. (SCI)
Chuah SK(co-first), Liang CM(co-first), Lee CH, Chiou SS, Chiu YC, Hu ML, Wu KL, Lu LS, Chou YP, Chang KC, Kuo CH, Kuo CM, Hu TH, Tai WC*. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication. Medicine (Baltimore). 2016 May;95(19):e3586. (SCI)
Wang HM, Tai WC, Chuah SK*, Lu HI, Lu LS, Liang CM, Kuo CH, Chiu YC, Wu KL, Changchien CS. Comparison of treatment outcomes of endoscope-guided pneumatic dilation and laparoscopic Heller myotomy. Kaohsiung J Med Sci. 2015 Dec;31(12):639-43. (SCI)
Hsu PI, Lu CL, Wu DC, Kuo CH, Kao SS, Chang CC, Tai WC, Lai KH, Chen WC, Wang HM, Cheng JS, Tsai TJ, Chuah SK*. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with los angeles grade a or B erosive esophagitis. Clin Gastroenterol Hepatol. 2015 May;13(5):859-866. (SCI)
Tai WC, Liang CM(co-first), Lee CH, Chiu CH, Hu ML, Lu LS, Kuo YH, Kuo CM, Yen YH, Kuo CH, Chiou SS, Wu KL, Chiu YC, Hu TH, Chuah SK*. Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A” Success Rate for First-Line Helicobacter pylori Eradication. Biomed Res Int. 2015 Jan;2015:623732. (SCI)
Chuah SK*, Wu DC, Suzuki H, Goh KL, Kao J, Ren JL. Peptic ulcer diseases: genetics, mechanism, and therapies. Biomed Res Int. 2014;2014:898349. Editorial (SCI)
Wang JH*, Chuah SK(co-first), Lu SN, Hung CH, Kuo CM, Tai WC, Chiou SS. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver Int. 2014 Oct;34(9):1340-8. (SCI)
Chuah SK, Tai WC(co-first), Lee CH*, Liang CM, Hu TH. Quinolone-Containing Therapies in the Eradication of Helicobacter pylori. BioMed Research International. 2014 Aug.; 2014 (2014): 151543. Review (SCI)
Tai WC, Lee CH, Chiou SS, Kuo CM, Kuo CH, Liang CM, Lu LS, Chiu CH, Wu KL, Chiu YC, Hu TH, Chuah SK*. The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication. PLoS One. 2014 Aug 20;9(8):e105822. (SCI)
Yang SC, Chen JC(co-first), Tai WC, Wu CK, Lee CH, Wu KL, Chiu YC, Wang JH, Lu SN, Chuah SK*. The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments. PLoS One. 2014 May 2;9(5):e96394. (SCI)
Tai WC, Chiu CH (co-first), Liang CM, Chang KC, Kuo CM, Chiu YC, Wu KL, Hu ML, Chou YP, Chiou SS, Chiu KW, Kuo CH, Lin MT, Hu TH, Chuah SK*. Ten-day versus 14-day Levofloxacin-containing Triple Therapy for Second-line anti-Helicobacter Pylori Eradication in Taiwan. Gastroenterol Res Pract. 2013;2013:932478. (SCI)
Yew KC, Chuah SK*. Antireflux endoluminal therapies: past and present. Gastroenterol Res Pract. 2013;2013:481417. (SCI)
Chuah SK, Chiu CH, Tai WC, Lee JH, Lu HI, Changchien CS, Tseng PH, Wu KL*. Current status in the treatment options for esophageal achalasia. World J Gastroenterol. 2013 Sep 7;19(33):5421-9. (SCI)
Wu CK, Wang JH, Lee CH, Wu KL, Tai WC, Lu SN, Hu TH, Chuah SK*. The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage. PLoS One. 2013 Apr 22;8(4):e61666. (SCI)
Yang SC, Wu KL, Wang JH, Lee CH, Kuo YH, Tai WC, Chen CH, Chiou SS, Lu SN, Hu TH, Changchien CS, Chuah SK*. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions. Hepatol Int. 2013 Mar;7(1):257-267. (SCI)
Chuah SK*, Tai WC, Hsu PI, Wu DC, Wu KL, Kuo CM, Chiu YC, Hu ML, Chou YP, Kuo YH, Liang CM, Chiu KW, Hu TH. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study. Helicobacter. 2012 Oct;17(5):374-81. (SCI)
Lin SC, Wu KL, Chiu KW, Lee CT, Chiu YC, Chou YP, Hu ML, Tai WC, Chiou SS, Hu TH, Changchien CS, Chuah SK*. Risk factors influencing the outcome of peptic ulcer bleeding in end stage renal diseases after initial endoscopic haemostasis. Int J Clin Pract. 2012 Aug;66(8):774-781. (SCI)
Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS*, Wu DC, Hu TH. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter. 2012 Jun;17(3):216-23. (SCI)
Chiu YC, Lu LS, Wu KL, Tam W, Hu ML, Tai WC, Chiu KW, Chuah SK*. Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage. BMC Gastroenterol. 2012 Jun 9;12:67. (SCI)
Chuah SK, Hsu PI, Wu KL*, Wu DC, Tai WC, Changchien CS. 2011 update on esophageal achalasia. World J Gastroenterol. 2012 Apr 14;18(14):1573-8. (SCI)
Liang CM, Lee JH (co-first), Kuo YH, Wu KL, Chiu YC, Chou YP, Hu ML, Tai WC, Chiu KW, Hu TH, Chuah SK*. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis. BMC Gastroenterol. 2012 Mar 28;12:28. (SCI)
Chuah SK, Wu KL*, Tai WC, Changchien CS. The effects of ginger on gallbladder motility in healthy male humans. J Neurogastroenterol Motil. 2011 Oct;17(4):411-5.
Chuah SK, Tsay FW, Hsu PI*, Wu DC. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol. 2011 Sep 21;17(35):3971-5. (SCI)
Xu HW, Wang JH, Tsai MS, Wu KL, Chiou SS, Changchien CS, Hu TH, Lu SN, Chuah SK*. The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc. 2011 Sep;25(9):2911-8. (SCI)
Chen CH, Chiu YC, Chou YP, Kuo CM, Wu KL, Chuah SK*. Cronkhite-Canada Syndrome: Report of a Case. Gastroenterol J Taiwan. 2011 Mar;28(1):57-61.
Hu ML, Wu KL, Chiu KW, Chiu YC, Chou YP, Tai WC, Hu TH, Chiou SS, Chuah SK*. Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers. World J Gastroenterol. 2010 Nov 21;16(43):5490-5. (SCI)
Tai WC, Hu TH, Lee CH, Chen HH, Huang CC, Chuah SK*. Ano-perianal tuberculosis: 15 years of clinical experiences in Southern Taiwan. Colorectal Dis. 2010 Jul;12(7 Online):e114-20. (SCI)
Chuah SK, Wu KL, Hu TH, Tai WC, Changchien CS*. Endoscope-guided pneumatic dilation for treatment of esophageal achalasia. World J Gastroenterol. 2010 Jan 28;16(4):411-7. Review. (SCI)
Hu ML, Lee CH, Kuo CM, Huang CC, Tai WC, Chang KC, Lee CM, Chuah SK*. Abdominal tuberculosis: analysis of clinical features and outcome of adult patients in southern Taiwan. Chang Gung Med J. 2009 Sep-Oct;32(5):509-16.
Lin MT, Tai WC, Chiu KW, Chou YP, Tsai MC, Hu TH, Lee CM, Changchien CS, Chuah SK*. Delayed presentation of intrathoracic esophageal perforation after pneumatic dilation for achalasia. World J Gastroenterol. 2009 Sep 21;15(35):4461-3. Review. (SCI)
Tai WC, Changchien CS, Hu TH, Huang CC, Chuah SK*, Lee CM. Pancreatic head cancer with distant duodenal metastasis: a case report with rare endoscopic presentations. Am J Med Sci. 2009 Jul;338(1):75-7. (SCI)
Chuah SK, Hu TH, Wu KL, Chen TY, Changchien CS*, Lee CM. The role of barium esophagogram measurements in assessing achalasia patients after endoscope-guided pneumatic dilation. Dis Esophagus. 2009;22(2):163-8. (SCI)
Chuah SK, Hu TH, Wu KL, Hsu PI, Tai WC, Chiu YC, Lee CM, Changchien CS*. Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg. 2009 May;13(5):862-7. (SCI)
Chuah SK, Hu TH, Wu KL, Tai WC, Chen TY, Chiu YC, Hu ML, Changchien CS*, Lee CM. Sonographic findings in esophageal achalasia. Chang Gung Med J. 2009 Mar-Apr;32(2):204-11.
Tai WC, Kuo CM, Lee CH, Chuah SK*, Huang CC, Hu TH, Wang JH, Chang KC, Tseng PL, Changchien CS, and Lee CM. Liver Tuberculosis in Southern Taiwan：15-years Clinical Experience . J Intern Med Taiwan 2008 Oct; 19(5): 410-417.
Kuo CM, Hu TH, Kuo CH, Luo YL, Lee CH, Huang CC, Changchien CS, Chuah SK*. Pseudomembranous colitis : A clinical report from southern Taiwan. J Intern Med Taiwan 2008 June; 19(3): 253-259.
Chen CH, Kuo Cm, Hu TH, Chuah SK*, Changchien CS. Colon Cytomegalovirus Infection：A Case Report With Rare Endoscopic Presentations. J Intern Med Taiwan 2008 Feb.; 19(1):67-71.
Chuah SK, Hu TH, Wu KL, Kuo CM, Fong TV, Lee CM, Changchien CS*. Endoscope-guided pneumatic dilatation of esophageal achalasia without fluoroscopy is another safe and effective treatment option: a report of Taiwan. Surg Laparosc Endosc Percutan Tech. 2008 Feb;18(1):8-12. (SCI)
